Graft Polymer Group

Graft Polymer Group is a specialty chemical company that specializes in polymer modification and the development of drug delivery systems. Founded in 2017, the company utilizes proprietary nano-methods and polymerization techniques to engineer polymer alloys at a molecular level, enabling the combination of otherwise incompatible materials. Its core technology, centered on creating unique composite materials, allows for the production of advanced polymer modifiers that improve physical performance, chemical resistance, and thermal properties. The company also operates a division called GraftBio, which focuses on intellectual property for bio-pharma applications, including drug delivery systems and health supplements.

These polymer solutions are designed to help industrial clients enhance their existing products, reduce raw material consumption, and lower manufacturing costs across various sectors such as healthcare, packaging, and engineering. By offering tailored, turn-key solutions and over 50 product grades—including adhesion promoters, rheology modifiers, and flame retardants—the company enables customers to meet higher technical and environmental standards. Graft Polymer operates research and manufacturing facilities in Slovenia and maintains a presence in the United Kingdom, where it has engaged with public markets to support its growth and research operations.